An Annals of Internal Medicine analysis found 87.5% of organizational comments opposed OMB's grant rule, with research groups ...
Anthropic's S-1 shows $9.74B of first-half R&D, more than any big U.S. drugmaker's ongoing R&D, and $14.2B over 12 months, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results